Vimarsana
Biggest News Aggregation in the World

Page 13 - Alacyclovir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alacyclovir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alacyclovir Today - Breaking & Trending Today

Monoclonal Antibodies Losing Effectiveness Against COVID-19 Variants - Vimarsana News

Monoclonal Antibodies Losing Effectiveness Against COVID-19 Variants

"Monoclonals had their day, like the Model T or the biplane," Carl Dieffenbach, director of the Division of AIDS at the National Institutes of Health and lead of the NIH's Antiviral Program for Pandemics.

AAP Issues Guidelines to Combat Rise in Respiratory Illness - Vimarsana News

AAP Issues Guidelines to Combat Rise in Respiratory Illness

Recommendations to manage an unprecedented wave of infections include extra doses of antiviral therapy for children at high risk.

Bepirovirsen: Is a 'Functional Cure' for HBV on the Horizon? - Vimarsana News

Bepirovirsen: Is a 'Functional Cure' for HBV on the Horizon?

The potential first-in-class antisense RNA-based therapy led to sustained clearance of HBsAg and HBV DNA for 24 weeks after treatment ended in the phase 2b study.

FDA Panel Votes Against Veru's COVID-19 Pill - Vimarsana News

FDA Panel Votes Against Veru's COVID-19 Pill

A panel of outside advisers to the US health regulator on Wednesday voted against authorizing Veru's drug for treating high-risk patients hospitalized with COVID-19, citing multiple concerns over efficacy and safety data being based on a small trial.

Paxlovid Cuts the Risk of Long COVID: VA Study - Vimarsana News

Paxlovid Cuts the Risk of Long COVID: VA Study

People who took Paxlovid had a 26% reduced risk of developing symptoms of long COVID such as fatigue and shortness of breath.